C. Michael Gibson says MOMENTUM found 27.3% of U.S. resistant hypertension patients had endogenous hypercortisolism and also highlighted hyperaldosteronism prevalence, arguing for broader endocrine screening in resistant HTN.
“Among U.S. patients with resistant HTN, 27.3% were found to have endogenous hypercortisolism”
“MOMENTUM study revealed high prevalence of hypercortisolism & hyperaldosteronism in U.S. resistant HTN patients, suggesting the importance of screening for both.”
Among U.S. patients with resistant HTN, 27.3% were found to have endogenous hypercortisolism
MOMENTUM study revealed high prevalence of hypercortisolism & hyperaldosteronism in U.S. resistant HTN patients
suggesting the importance of screening for both.
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new expert voices, debates, and emerging ideas.
← Back to Healthcare